3-[2-(chloromethyl)-7-methylbenzimidazol-1-yl]thiane 1,1-dioxide
C14H17ClN2O2S — CID 115553525
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-(chloromethyl)-7-methylbenzimidazol-1-yl]thiane 1,1-dioxide
3-[2-(chloromethyl)-7-methylbenzimidazol-1-yl]thiane 1,1-dioxide (PubChem CID 115553525) has the molecular formula C14H17ClN2O2S and a molecular weight of 312.82 g/mol. Its IUPAC name is 3-[2-(chloromethyl)-7-methylbenzimidazol-1-yl]thiane 1,1-dioxide.
Molecular Properties
| Compound Name | 3-[2-(chloromethyl)-7-methylbenzimidazol-1-yl]thiane 1,1-dioxide |
|---|---|
| PubChem CID | 115553525 |
| Molecular Formula | C14H17ClN2O2S |
| Molecular Weight | 312.82 g/mol |
| Exact Mass | 312.07 |
| IUPAC Name | 3-[2-(chloromethyl)-7-methylbenzimidazol-1-yl]thiane 1,1-dioxide |
| SMILES | Cc1cccc2nc(CCl)n(C3CCCS(=O)(=O)C3)c12 |
| InChI | InChI=1S/C14H17ClN2O2S/c1-10-4-2-6-12-14(10)17(13(8-15)16-12)11-5-3-7-20(18,19)9-11/h2,4,6,11H,3,5,7-9H2,1H3 |
| InChIKey | FCNRJEPIMOHDKI-UHFFFAOYSA-N |
| XLogP | 2.83 |
| TPSA | 51.96 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 20 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 312.82 |
| LogP ≤ 5 | 2.83 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 115553525 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.